- **PRO-DEX, INC.** reported **net sales** of **$18.5 million** for the first fiscal quarter ended September 30, 2025, representing a **24% increase** from **$14.9 million** in the prior year period, primarily driven by the resumption of shipments for a next-generation handpiece.  **[788920_0001079973-25-001656_ex99x1.htm:1]** **[788920_0001079973-25-001656_ex99x1.htm:3]** 
- **Net income** for the quarter significantly increased to **$4.7 million**, or **$1.40 per diluted share**, compared to **$2.5 million**, or **$0.75 per diluted share**, in the corresponding prior year quarter.  **[788920_0001079973-25-001656_ex99x1.htm:1]** **[788920_0001079973-25-001656_ex99x1.htm:3]** 
- This substantial increase in net income was largely attributable to **$3.3 million** in unrealized gains on marketable equity investments, which was significantly higher than the **$433,000** reported in the year-ago quarter.  **[788920_0001079973-25-001656_ex99x1.htm:1]** 
- The company also received **$8.9 million** in cash proceeds from the acquisition of its investment in Monogram Technologies, Inc. by Zimmer Biomet Holdings, Inc..  **[788920_0001079973-25-001656_ex99x1.htm:1]**

PRO DEX (PDEX)